Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified is the 392nd most traded HS4 level product.

In 2023, the top countries where Estonia exported Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified to were Russian Federation (€3.51M), Lithuania (€2.29M), Latvia (€684k), Germany (€218k), and Canada (€189k). During the same period, Estonia imported Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified from Germany (€26.8M), Lithuania (€16.8M), Austria (€13M), Switzerland (€10.4M), and Poland (€4.32M).

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified is a 4 digit product (HS4 ID 3002).